Xiaocong Pang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Sphingolipid Metabolism and Signaling
- Circular RNAs in diseases
- FOXO transcription factor regulation
Papers in
-
- Circular RNAs in diseases 5
-
- Ferroptosis and cancer prognosis 5
- Prostate Cancer Treatment and Research 4
- Co-authors
- Yimin Cui (20 shared papers)Guanhua Du (8 shared papers)Shiliang Wu (3 shared papers)Jinhua Wang (7 shared papers)Xiaodan Zhang (2 shared papers)Bin‐Zhi Qian (2 shared papers)Xiangjin Zheng (4 shared papers)Kan Gong (1 shared paper)
- Journals
- Frontiers in Immunology (4 papers)Pharmacological Research (4 papers)Advanced Healthcare Materials (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Pharmacology & Therapeutics (2 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Xiaocong Pang
39 papers receiving 861 citations
Peers
Comparison fields: 5 of 100
- Cancer Research 230
- Molecular Biology 506
- Oncology 168
- Immunology 116
- Pulmonary and Respiratory Medicine 153
Countries citing papers authored by Xiaocong Pang
This map shows the geographic impact of Xiaocong Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaocong Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaocong Pang more than expected).
Fields of papers citing papers by Xiaocong Pang
This network shows the impact of papers produced by Xiaocong Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaocong Pang. The network helps show where Xiaocong Pang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaocong Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 145 | |
| 2 | 2018 | 97 | |
| 3 | 2021 | 53 | |
| 4 | 2017 | 50 | |
| 5 | 2020 | 46 | |
| 6 | 2015 | 39 | |
| 7 | 2021 | 38 | |
| 8 | 2016 | 38 | |
| 9 | 2018 | 37 | |
| 10 | 2019 | 37 | |
| 11 | 2023 | 36 | |
| 12 | 2019 | 29 | |
| 13 | 2017 | 26 | |
| 14 | 2023 | 20 | |
| 15 | 2021 | 18 | |
| 16 | 2024 | 16 | |
| 17 | 2024 | 14 | |
| 18 | 2017 | 14 | |
| 19 | Expression of the MAGE-1 gene in human hepatocellular carcinomas. | 2000 | 14 |
| 20 | 2022 | 13 |
About Xiaocong Pang
Xiaocong Pang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 45 papers that have together received 873 indexed citations. Recurring topics across this work include Circular RNAs in diseases (5 papers), Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Prostate Cancer Treatment and Research (4 papers), Alzheimer's disease research and treatments (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (230 citations), Molecular Biology (506 citations), Oncology (168 citations), Immunology (116 citations) and Pulmonary and Respiratory Medicine (153 citations). Xiaocong Pang has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Yimin Cui, Guanhua Du, Shiliang Wu, Jinhua Wang, Xiaodan Zhang, Bin‐Zhi Qian, Xiangjin Zheng, Kan Gong, Yi Zhun Zhu and Jinyi Liu. Their work appears in journals such as Frontiers in Immunology, Pharmacological Research, Advanced Healthcare Materials, Oxidative Medicine and Cellular Longevity and Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.